On Wednesday, Geneone Life Science Inc. declared their plan to generate 2.5 billion won (US$1.9 million) through the sale of stocks. The money will primarily be allocated to finance the company’s activities.
The filing with the regulatory body mentioned that 722,218 common stocks will be sold at a price of 3,420 won per share. The investors who have been selected by the firm will be the ones to acquire the stocks.
(END)